136 related articles for article (PubMed ID: 34569655)
1. Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds.
Sever B; Türkeş C; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş
Arch Pharm (Weinheim); 2021 Dec; 354(12):e2100294. PubMed ID: 34569655
[TBL] [Abstract][Full Text] [Related]
2. Thiazolyl-pyrazoline derivatives: In vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors.
Sever B; Türkeş C; Altıntop MD; Demir Y; Beydemir Ş
Int J Biol Macromol; 2020 Nov; 163():1970-1988. PubMed ID: 32931834
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, molecular docking and biological activities of novel pyrazoline derivatives.
Turkan F; Cetin A; Taslimi P; Karaman HS; Gulçin İ
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800359. PubMed ID: 31125504
[TBL] [Abstract][Full Text] [Related]
4. Investigation of inhibitory properties of some hydrazone compounds on hCA I, hCA II and AChE enzymes.
Kucukoglu K; Gul HI; Taslimi P; Gulcin I; Supuran CT
Bioorg Chem; 2019 May; 86():316-321. PubMed ID: 30743172
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structure elucidation, and in vitro pharmacological evaluation of novel polyfluoro substituted pyrazoline type sulfonamides as multi-target agents for inhibition of acetylcholinesterase and carbonic anhydrase I and II enzymes.
Yamali C; Gul HI; Kazaz C; Levent S; Gulcin I
Bioorg Chem; 2020 Mar; 96():103627. PubMed ID: 32058104
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors.
Turkan F; Cetin A; Taslimi P; Karaman M; Gulçin İ
Bioorg Chem; 2019 May; 86():420-427. PubMed ID: 30769267
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors.
Askin S; Tahtaci H; Türkeş C; Demir Y; Ece A; Akalın Çiftçi G; Beydemir Ş
Bioorg Chem; 2021 Aug; 113():105009. PubMed ID: 34052739
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, cytotoxicity and carbonic anhydrase inhibitory activities of new pyrazolines.
Kucukoglu K; Oral F; Aydin T; Yamali C; Algul O; Sakagami H; Gulcin I; Supuran CT; Gul HI
J Enzyme Inhib Med Chem; 2016; 31(sup4):20-24. PubMed ID: 27579806
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of some new pyrazolines and their inhibitory potencies against carbonic anhydrases.
Çelik G; Arslan T; Şentürk M; Ekinci D
Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900292. PubMed ID: 31922298
[TBL] [Abstract][Full Text] [Related]
10. Novel benzoic acid derivatives: Synthesis and biological evaluation as multitarget acetylcholinesterase and carbonic anhydrase inhibitors.
Kalaycı M; Türkeş C; Arslan M; Demir Y; Beydemir Ş
Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000282. PubMed ID: 33155700
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides.
Mete E; Comez B; Inci Gul H; Gulcin I; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(sup2):1-5. PubMed ID: 27435177
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and bioactivities of pyrazoline benzensulfonamides as carbonic anhydrase and acetylcholinesterase inhibitors with low cytotoxicity.
Ozmen Ozgun D; Gul HI; Yamali C; Sakagami H; Gulcin I; Sukuroglu M; Supuran CT
Bioorg Chem; 2019 Mar; 84():511-517. PubMed ID: 30605787
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in silico studies of triazene-substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitors.
Bilginer S; Gul HI; Anil B; Demir Y; Gulcin I
Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000243. PubMed ID: 32984993
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and molecular modelling studies of some pyrazole derivatives as carbonic anhydrase inhibitors.
Dizdaroglu Y; Albay C; Arslan T; Ece A; Turkoglu EA; Efe A; Senturk M; Supuran CT; Ekinci D
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):289-297. PubMed ID: 31797703
[TBL] [Abstract][Full Text] [Related]
15. Novel eugenol derivatives: Potent acetylcholinesterase and carbonic anhydrase inhibitors.
Topal F; Gulcin I; Dastan A; Guney M
Int J Biol Macromol; 2017 Jan; 94(Pt B):845-851. PubMed ID: 27984137
[TBL] [Abstract][Full Text] [Related]
16. Discovery of sulfadrug-pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors.
Gümüş M; Babacan ŞN; Demir Y; Sert Y; Koca İ; Gülçin İ
Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100242. PubMed ID: 34609760
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
[TBL] [Abstract][Full Text] [Related]
18. The green synthesis and molecular docking of novel N-substituted rhodanines as effective inhibitors for carbonic anhydrase and acetylcholinesterase enzymes.
Bayindir S; Caglayan C; Karaman M; Gülcin İ
Bioorg Chem; 2019 Sep; 90():103096. PubMed ID: 31284100
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of chalcone-imide derivatives and investigation of their anticancer and antimicrobial activities, carbonic anhydrase and acetylcholinesterase enzymes inhibition profiles.
Kocyigit UM; Budak Y; Gürdere MB; Ertürk F; Yencilek B; Taslimi P; Gülçin İ; Ceylan M
Arch Physiol Biochem; 2018 Feb; 124(1):61-68. PubMed ID: 28792233
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, molecular modeling, and biological evaluation of 4-[5-aryl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl] benzenesulfonamides toward acetylcholinesterase, carbonic anhydrase I and II enzymes.
Yamali C; Gul HI; Ece A; Taslimi P; Gulcin I
Chem Biol Drug Des; 2018 Apr; 91(4):854-866. PubMed ID: 29143485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
